IRB Meeting Dates and Submission Deadlines

The IRB meets for full-board meetings on the second Wednesday of every month. To ensure your study is given appropriate review in a timely manner, study submissions must be submitted by the deadlines indicated below for each meeting. This does not apply to continuing review submissions, which have their own specific deadlines.

There are no deadlines for submissions requiring an exemption determination or expedited review. These are accepted and reviewed on a rolling basis.

The current IRB meeting dates and submission deadlines are:

Remaining 2017 and all 2018 IRB Meeting Dates Submission of Initial Applications and Continuing Review Deadlines Submission of Amendment Deadlines
December 13 November 29 December 1
January 10 December 28 January 1
February 14 January 31 February 2
March 14 February 28 March 2
April 11 March 28 March 30
May 19 April 25 April 27
June 13 May 30 June 1
July 11 June 27 June 29
August 8 July 25 July 27
September 12 August 29 August 31
October 10 September 26 September 28
November 14 October 31 November 2
December 12 November 28 November 30

*Note: Submissions received on the deadline date must be complete and review ready to be placed on the Agenda for review at next convened board meeting.

Training and Education

MCP IRB requires all individuals involved in the conduct of human subjects research to complete human subjects protection training and to ensure that training is current for every year while the study is under active IRB oversight. IRB approval will be withheld if these training requirements are not met.

These requirements apply to all persons with a significant role in the research, such as those designated as:

  • Principal Investigator and Co-investigators,
  • Individuals named on a study grant or contract proposal,
  • Individuals listed on an FDA form 1572 for the conduct of the research at MCP or at an affiliate institution,
  • Individuals named as a contact person in the informed consent document(s) or recruitment materials for research,
  • Individuals who obtain informed consent from prospective participants in research, and
  • Individuals who obtain individually identifiable health information under a Business Associate Agreement.

At a minimum, MCP IRB will accept evidence of completion of the online National Institutes of Health (NIH) Office of Extramural Research module entitled “Protecting Human Research Participants” or The Collaborative Institutional Training Initiative (CITI) program training.

NIH training

CITI training

If training was completed at another institution, please upload a copy of the training certificate to IRBNet with the materials for the particular review package.